Testosterone 17 beta-cypionate clinical trials
Also written Testosterone cypionate and Depo-Testosterone.
Its developmentBy Amneal Pharmaceuticals and Azurity Pharmaceuticals, step by step2 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.A product of Testosterone; its studies count on that page too.
How each study uses testosterone 17 beta-cypionate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the testosterone 17 beta-cypionate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Jun 1978 · TESTOSTERONE CYPIONATE · ANDA 086029 (FDA, Drugs@FDA)
- European Union
- 28 Jul 2006 · Livensa · EMEA/H/C/000630 (EMA; as Testosterone; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
26 studies that test it; most in 2026 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 25
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · Brigham and Women's Hospital (2) · University of Miami (2) · VA Office of Research and Development (2) · University of California, San Diego (2) · Roswell Park Cancer Institute (1) · Emory University (1) · Leticia Maria Defendi Barboza Marson (1)
Often tested with
Tested in the same studies.
Leuprolide (2) · Darolutamide (2) · Testosterone enanthate (2) · Bupropion (1) · Anastrozole (1) · Danazol (1) · Chlorthalidone (1) · Enzalutamide (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Testosterone source
- One of Anabolic Agents source
- One of Androgens source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test testosterone 17 beta-cypionate, phase 3 first.
- Mar 2027Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismPhase 3 · Amneal Pharmaceuticals, LLC
- Dec 2026The Anabolic Effect of Testosterone on Pelvic Floor MusclesPhase 2 · Brigham and Women's Hospital
- Jun 2027Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenPhase 4 · Azurity Pharmaceuticals
Studies
Open first, then newest update. How each study uses testosterone 17 beta-cypionate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 27
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceRecruitingPhase 4University of MiamiNCT07278362Written as Testosterone cypionate
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismRecruitingPhase 3Amneal Pharmaceuticals, LLCNCT07898072Written as Testosterone Cypionate 75 mg
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingPhase 2/3VA Office of Research and DevelopmentNCT07742553Written as testosterone cypionate
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Testosterone Cypionate
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07142551Written as Testosterone cypionate
- Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenNot yet recruitingPhase 4Azurity PharmaceuticalsNCT07328542Written as Testosterone Cypionate Injection 200 mg/mL
- Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)CompletedPhase 2Latin American Cooperative Oncology GroupNCT04558866Written as Testosterone Cypionate
- Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingPhase 1Roswell Park Cancer InstituteNCT06305598Written as Testosterone Cypionate
- Improving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyCompletedPhase 2Dana-Farber Cancer InstituteNCT03716739Written as Testosterone Cypionate 100 MG/ML
- The Anabolic Effect of Testosterone on Pelvic Floor MusclesActive, not recruitingPhase 2Brigham and Women's HospitalNCT06111209Written as Testosterone cypionate
- Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low TestosteroneActive, not recruitingPhase 1Emory UniversityNCT04731376Written as Testosterone Cypionate
- Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)CompletedPhase 2Brigham and Women's HospitalNCT04895306Written as Testosterone Cypionate
- Androgen Effects on the Reproductive Neuroendocrine AxisTerminatedPhase 4University of California, San DiegoNCT06450405Written as Testosterone Cypionate 50 MG/ML Injectable Solution
- Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with ErythrocytosisCompletedNot applicableUniversity of Sao PauloNCT05487794Written as Testosterone Cypionate 100 MG/ML
- Hormone Secretion in Transgender MalesWithdrawnPhase 4University of California, San DiegoNCT04321551Written as Testosterone Cyp 200Mg/Ml Inj (in Oil)
- TESTO-TRIAL: Use of Testosterone in Critically Ill PatientsActive, not recruitingPhase 4Leticia Maria Defendi Barboza MarsonNCT06592144Written as Testosterone cypionate (200mg/3ml)
- Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate CancerTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02995330Written as testosterone cypionate
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsCompletedPhase 4University of MiamiNCT04439799Written as Testosterone Cypionate 200 Mg/ML
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen TherapyCompletedPhase 2Hospital Sirio-LibanesNCT04424654Written as Testosterone cypionate
- Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff RepairWithdrawnPhase 2/3Orthopedic Institute, Sioux Falls, SDNCT04345666Written as Testosterone cypionate
See all 27 studies that test testosterone 17 beta-cypionate →
Given beside what is tested · 10 — testosterone 17 beta-cypionate is usual care or a partner of the new treatment
- The COSMYC Trial (COmbined Suppression of MYC)RecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06922318Written as Testosterone cypionate
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Testosterone Cypionate
- Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPCRecruitingPhase 2Yale UniversityNCT06100705Written as Testosterone Cypionate
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyRecruitingPhase 2University of WashingtonNCT06039371Written as Testosterone Cypionate
- Sequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04363164Written as Testosterone cypionate
- Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPCRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT07476001Written as Testosterone cypionate (Tc)
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06059118Written as testosterone cypionate
- Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerCompletedPhase 2University of WashingtonNCT03516812Written as Testosterone Cypionate
- COMbination of Bipolar Androgen Therapy and NivolumabCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03554317Written as Testosterone cypionate
- RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)CompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02090114Written as Testosterone cypionate
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting1
Newly registered1
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismOct 27, 2026NCT07898072
Codes
What other systems call testosterone 17 beta-cypionate · ClinicalTrials.gg INT002641
- MeSH (NLM) C016131testosterone 17 beta-cypionateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) M0XW1UBI14TESTOSTERONE CYPIONATEConfirmed FDA, NLM
- RxNorm 835827One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016131 | testosterone 17 beta-cypionate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | M0XW1UBI14 | TESTOSTERONE CYPIONATE | Confirmed FDA, NLM |
| RxNorm | 835827 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.